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low prevalence of abdominal aortic aneurysm in the 
seychelles population aged 50 to 65 years
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abstract
The prevalence of abdominal aortic aneurysm (AAA) and its 
risk factors are well known in Western countries but few data 
are available from low- and middle-income countries. We are 
not aware of systematically collected population-based data 
on AAA in the African region. We evaluated the prevalence of 
AAA in a population-based cardiovascular survey conducted 
in the Republic of Seychelles in 2004 (Indian Ocean, African 
region). Among the 353 participants aged 50 to 64 years and 
screened with ultrasound, the prevalence of AAA was 0.3% 
(95% CI: 0–0.9) and the prevalence of ectatic dilatations 
of the abdominal aorta was 1.5% (95% CI: 0.2–2.8). The 
prevalence of AAA in the general population seemed lower 
in Seychelles than in Western countries, despite a high preva-
lence in Seychelles of risk factors of AAA, such as smoking 
(in men), high blood pressure and hypercholesterolaemia.
Keywords: abdominal aortic aneurysm, screening, ultrasonogra-
phy, population-based study, African region
Submitted 22/3/12, accepted 8/10/12
Published online 13/11/12
Cardiovasc J Afr 2013; 24: 17–18 www.cvja.co.za
DOI: 10.5830/CVJA-2012-070
Recent clinical trials have demonstrated a reduction in 
mortality related to abdominal aortic aneurysm (AAA) in men 
systematically screened with ultrasound at age 65 to 74 years.1-4 
Risk factors of AAA include male gender, age and smoking, and 
to a lesser extent hypertension, hypercholesterolaemia and overt 
atherosclerosis.5,6 The US Preventive Services task force has 
recommended the screening of AAA in men aged 65 to 75 years 
who have ever smoked.7
In view of the limited population-based data on AAA available 
in low- and middle-income countries,8,9 and none that we are 
aware of in the African region, we examined the prevalence of 
AAA in a population-based survey of cardiovascular risk factors 
conducted in the Republic of Seychelles in 2004. Seychelles is 
a rapidly developing middle-income island state located in the 
Indian Ocean approximately 1 800 km east of Kenya (African 
region).
In 2004, 42.8% of the population was aged less than 25 
years and 9.7% was 50 to 64 years old. The majority of the 
inhabitants is of African descent and a high prevalence of several 
cardiovascular risk factors was previously demonstrated in the 
population, particularly high blood pressure.10,11
Methods
A random age- and gender-stratified sample of all inhabitants 
aged 25 to 64 years was drawn using computerised data of a 
national census carried out in 2002 and thereafter regularly 
updated by civil status authorities. Methods of the survey have 
been described previously.12 
From a total of 1 456 eligible participants (participation rate 
80.2%), 566 were aged 50 to 64 years, and 474 took part in 
the survey (participation rate 83.7%). We restricted the AAA 
screening to this age range because AAA is rare at younger 
ages.13,14
Ultrasound (General Electric LogiqBook connected to a 
2–5-MHz transducer, General Electric Health Care, United 
Kingdom) was performed in the 353 consecutive individuals 
who took part in the survey during a 17-week period when a 
sonographer was available. The abdominal aorta was scanned 
from its most proximal visualisable segment to the iliac 
bifurcation, both transversally and longitudinally. Its antero–
posterior and transverse diameters were measured at their 
maximal sizes, and the larger of the two values was recorded.  
results
None of the screened subjects had a history of AAA. The 
maximal diameter of the aorta could be well visualised in 329 of 
the 351 eligible participants. AAA, defined as a diameter ≥ 30 
mm, was found in only one man (diameter 31 mm, age 59 years, 
never-smoker, obese, cholesterol 6.7 mmol/l, hypertensive, 
diabetic). An ectatic dilatation of the aorta (diameter 25–29 
mm), which can be regarded as precursor of AAA,15 was found 
in four additional participants: three men and one woman (age: 
52, 59, 62 and 63; two ex-smokers; all overweight; three with 
hypertension; two with diabetes; total cholesterol: 5.0, 6.0, 6.3 
and 7.4 mmol/l, respectively).
The prevalence of aneurysm or ectasy of the abdominal aorta 
of all participants aged 50 to 64 years is shown in Table 1. In the 
same age category, the prevalence was 15% for current smokers 
(28% in men, 3% in women), 22% for ex-smokers (32% in men 
and 3% in women), 70% for overweight participants (body mass 
index ≥ 25 kg/m2), 33% for obesity (≥ 30 kg/m2), 70% for high 
blood pressure (≥ 140/90 mmHg or treatment), 27% for diabetes 
mellitus and 63% for elevated total cholesterol levels (≥ 5.2 
mmol/l).
department of Internal Medicine, division of Cardiology, 
lausanne university Hospital (CHuV), lausanne, switzerland
PATRiCK YERLY, MD, patrick.yerly@erasme.ulb.ac.be
unit for Prevention and Control of Cardiovascular disease, 
Ministry of Health, Victoria, seychelles
GEORGE MADELEiNE
Institute of Clinical Chemistry and Haematology, Canton 
Hospital, st Gallen, switzerland
WALTER RiESEN, MD 
Institute of social and Preventive Medicine (IuMsP), 
lausanne university Hospital, lausanne, switzerland
PASCAL BOVET, MD
CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 2, March 201318 AFRICA
discussion
The prevalence of AAA in the general population aged 50 to 
64 years seemed lower in Seychelles than in North America 
or Europe. In North America, in participants aged 50–54/55–
59/60–64 years, the prevalence of AAA was 0.9/2.5/4.2% in 
smokers and 0.2/0.5/0.9% in non-smokers, respectively.4,7 In 
Norway, the prevalence of AAA in men/women was 1.9/0% and 
6.0/1.1% at ages 45–54 and 55–64 years, respectively.13 In the 
Netherlands the prevalence of AAA in men/women was 0.9/0.2% 
and 3.1/0.4% at ages 55–59 and 60–64 years, respectively.16 
In contrast to what was recently described in a population of 
mainly symptomatic aortic aneurysm patients in Kenya, we did 
not find a female predominance for the diagnosis of AAA in 
Seychelles. This was despite the predominant African descent of 
the population and the prevalence of high blood pressure in the 
50- to 64-year age category, which was the leading risk factor 
associated with aortic aneurysms in this study.17 This apparent 
inconsistency might be due to methodological factors, such as 
gender differences in health-related habits, since the Kenyan study 
was based on hospital records and not on population-based data.
A low prevalence of AAA in Seychelles might be consistent 
with a high prevalence of diabetes and the predominantly African 
descent of the population, which are two factors reported to be 
inversely associated with AAA.6,7 It is however at odds with a 
high prevalence of smoking (in men), high blood pressure and 
hypercholesterolaemia in the Seychelles population. 
Alternatively, we cannot exclude some imprecision in our 
estimates in view of the relatively small size of our sample and 
broad confidence intervals, although the population-based design 
of the study as well as the high participation rate strengthens the 
reliability of our epidemiological data. On the other hand, the 
seemingly higher prevalence of aortic ectatic dilatation could 
announce increasing rates of AAA in the next decades as the 
population becomes exposed to high risk-factor levels over long 
periods of time. 
Furthermore, because of a high prevalence of AAA risk 
factors, such as current smoking (28% in men and 4% in women 
aged 40–49 years) or high blood pressure (35% in the 40–49-
year population) in younger age groups with a lower prevalence 
of ‘protective factors’ such as diabetes mellitus (11.7% in 
the 40–49-year population), ectatic lesions might appear at a 
younger age in Seychelles than in North America or Europe. 
However, given the small rate of expansion of small lesions over 
time, the finding of true AAA in subjects aged less than 50 years 
is unlikely.18 
Conclusion
Pending further data on the prevalence of AAA in older age 
categories, our results do not support routine screening of AAA in 
the selected population. This is consistent with recommendations 
for populations in Western countries.5 
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TABLE 1. PREVALENCE OF ANEURYSM OR ECTASY  
OF THE ABDOMINAL AORTA IN THE GENERAL  
POPULATION OF SEYCHELLES AGED 50–64 YEARS
Men (n = 151) Women (n = 178) Total (n = 329)
% 95% CI % 95% CI % 95% CI
Aneurysm 0.7 0–2.0 0 0.3 0–0.9
Ectasy 2.0 0–4.2 0.6 0–1.7 1.2 0–2.4
Either 2.7 0.1–5.2 0.6 0–1.7 1.5 0.2–2.8
